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ARTICLE
Imbalanced social-communicative and restricted
repetitive behavior subtypes of autism spectrum
disorder exhibit different neural circuitry
Natasha Bertelsen1,2, Isotta Landi1, Richard A. I. Bethlehem 3, Jakob Seidlitz 4,5, Elena Maria Busuoli1,2,
Veronica Mandelli1,2, Eleonora Satta1, Stavros Trakoshis1,6, Bonnie Auyeung7,8, Prantik Kundu9, Eva Loth10,11,
Guillaume Dumas12, Sarah Baumeister13, Christian F. Beckmann14, Sven Bölte15,16,17, Thomas Bourgeron 12,
Tony Charman 18, Sarah Durston19, Christine Ecker20, Rosemary J. Holt8, Mark H. Johnson21,
Emily J. H. Jones22, Luke Mason22, Andreas Meyer-Lindenberg23, Carolin Moessnang23,
Marianne Oldehinkel14,24, Antonio M. Persico 25,26, Julian Tillmann18,27, Steve C. R. Williams28,
Will Spooren29, Declan G. M. Murphy10,11, Jan K. Buitelaar14, the EU-AIMS LEAP group*, Simon Baron-Cohen8,
Meng-Chuan Lai8,30,31,32,33 & Michael V. Lombardo 1,8✉
Social-communication (SC) and restricted repetitive behaviors (RRB) are autism diagnostic
symptom domains. SC and RRB severity can markedly differ within and between individuals
and may be underpinned by different neural circuitry and genetic mechanisms. Modeling
SC-RRB balance could help identify how neural circuitry and genetic mechanisms map onto
such phenotypic heterogeneity. Here, we developed a phenotypic stratification model that
makes highly accurate (97–99%) out-of-sample SC= RRB, SC > RRB, and RRB > SC subtype
predictions. Applying this model to resting state fMRI data from the EU-AIMS LEAP dataset
(n= 509), we find that while the phenotypic subtypes share many commonalities in terms of
intrinsic functional connectivity, they also show replicable differences within some networks
compared to a typically-developing group (TD). Specifically, the somatomotor network
is hypoconnected with perisylvian circuitry in SC > RRB and visual association circuitry in
SC= RRB. The SC= RRB subtype show hyperconnectivity between medial motor and
anterior salience circuitry. Genes that are highly expressed within these networks show a
differential enrichment pattern with known autism-associated genes, indicating that such
circuits are affected by differing autism-associated genomic mechanisms. These results
suggest that SC-RRB imbalance subtypes share many commonalities, but also express subtle
differences in functional neural circuitry and the genomic underpinnings behind such
circuitry.
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Autism spectrum disorder (ASD) is a clinical consensuslabel used to characterize individuals with a collection ofearly onset developmental difficulties in the domains of
social-communication (SC) and restricted repetitive behaviors
(RRB)1,2. The single diagnostic label of autism helps many indi-
viduals in a variety of ways by being incorporated into a sense of
identity, explaining challenging aspects of life, and/or enabling
access to services. However, the diagnosis also encapsulates a vast
amount of multi-scale heterogeneity. In the face of such hetero-
geneity, future translational research must develop a deeper
understanding of how biological mechanisms affect individuals
and must develop more personalized approaches towards inter-
ventions to help facilitate positive outcomes3.
Because heterogeneity manifests across every scale from phe-
nome to genome, it is important to understand whether top-down
phenotypic stratifications may be useful. For example, there is
evidence to suggest that important phenotypic stratifications could
be made based on the balance between SC and RRB domains. Prior
work has suggested that SC and RRB domains could be fractionable
at behavioral4 and neural levels5–7 and potentially underpinned by
different genetic mechanisms8–11. However, robust evidence of this
phenotypic fractionation mapping onto differential neural circuitry
and genomic mechanisms has yet to be identified. The potential
multi-scale fractionation of these domains provides a strong starting
point for understanding how multi-scale heterogeneity manifests in
autism from genome to phenome.
In this work, we test the hypothesis that subtyping individuals
by the degree of SC-RRB balance can help identify differential
biological mechanisms. Past research utilizing “gold standard”
diagnostic tools such as the Autism Diagnostic Observation
Schedule (ADOS) and the Autism Diagnostic Interview-Revised
(ADI-R) (e.g.,12–14) have suggested the presence of 3 SC-RRB
balance subtypes: (1) medium to high levels of both SC and
RRB severity (SC= RRB); (2) medium to high SC severity
and comparatively lower RRB severity (SC > RRB); and (3)
medium to high RRB severity and comparatively lower SC
severity (RRB > SC). These subtypes might be underpinned by a
common pathway if they showed similar neural circuits and
genomic mechanisms that differ from a typically-developing (TD)
comparison group. However, based on the hypothesis that SC and
RRB domains are fractionable across multiple levels, it could be
that these subtypes diverge onto multiple atypical pathways from
genome to phenome15 (Fig. 1). This idea has not yet been tested
with respect to macroscale neural circuitry and its link to func-
tional genomic mechanisms. Here we evaluate how SC-RRB
balance subtypes link up to differential macroscale connectome
phenotypes, measured with resting state fMRI (rsfMRI) func-
tional connectivity. Functional connectivity networks are known
to be linked to underlying transcriptomic mechanisms, particu-
larly with regards to the spatial patterning of gene expression
across the brain (e.g.,16–18). Given that subtypes could exhibit
different functional connectome phenotypes, we leverage the link
between macroscale rsfMRI functional networks and tran-
scriptomic mechanisms to better understand whether autism-
relevant functional genomic mechanisms differentially affect such
phenotypes.
To test these ideas, we developed a stratification approach that
subtypes individuals based on the within-individual balance
between SC versus RRB severity, as measured by ADI-R data from
thousands of individuals (n= 2,628) obtained from the National
Database for Autism Research (NDAR) (https://nda.nih.gov). This
approach can be used to make highly accurate out-of-sample
subtype predictions and thus can be applicable to any new dataset
where ADI-R data is collected. We applied this SC-RRB balance
stratification model to the deeply phenotyped EU-AIMS LEAP
dataset19–21 to examine how functional connectivity may differ
between SC-RRB balance subtypes or relative to a typically-
developing (TD) comparison group. While SC-RRB balance
subtypes are important to test, it may be also useful to consider
overall level of SC and RRB severity as important and to char-
acterize this severity in a continuous manner. Thus, we also
evaluate other possible continuous/dimensional models that
examine SC and RRB separately as well as using SC-RRB balance
score as a continuous variable. Finally, in order to link functional
connectome phenotypes to autism-associated genes, we utilize the
Allen Institute Human Brain Atlas22,23 to identify genes whose
spatial expression pattern is highly similar to macroscale func-
tional networks that differ amongst the SC-RRB subtypes. These
functional network-relevant gene lists are then investigated for
enrichment in a variety of autism-associated gene lists derived
from evidence at genetic or transcriptomic levels. This will allow
for tests of the hypothesis that subtype disruption of imaging-
derived phenotypes preferentially occurs to macroscale networks
with high levels of gene expression of autism-associated genes24.
This approach will also allow us to test whether autism-associated
genes affect networks similarly or differently across the SC-RRB
balance subtypes.
Results
Highly accurate out-of-sample prediction of SC-RRB balance
subtypes. In our first set of analyses, we sought to develop a
model to predict ADI-R SC-RRB balance subtypes from the
NDAR datasets. Relatively equal Discovery (n= 889) and Repli-
cation (n= 890) datasets were partitioned from the total
n= 1,781 individuals in NDAR and this split into Discovery and
Replication was balanced as a function of the originating datasets
and sex. Using z-normalized difference scores, we split the dataset
into SC= RRB, SC > RRB, and RRB > SC subtypes (Fig. 2A,
source data for Fig. 2 can be found in Supplementary Data 1).
Importantly, the subtype labels were first defined separately in
Discovery and Replication sets based on the statistical norms (i.e.,
mean and SD) estimated on each set. This ensures that the
definition of the labels in each set is done independently of the
other. If the statistical norms for the computation of z-normalized
difference scores (e.g., mean and SD) are highly similar between
Discovery and Replication, then the subtyping model learned
from the Discovery set will likely be highly generalizable and
produce high accuracy values in the Replication set. However, if
the statistical norms are highly different between Discovery and
Replication, the model learned from Discovery data will not
generalize well to the labels in the Replication set and would thus
produce poor out-of-sample prediction accuracy.
Applying this approach across a range of z-thresholds (e.g.,
z= 0.5 up to z= 1 in steps of 0.1), we find that out-of-sample
prediction accuracy is very high (e.g., 97–99%) (see Fig. 2B). The
reason for this high accuracy is visually evident in the high
degree of similarity in distributions of Discovery and Replication
sets in the scatterplots in Fig. 2A. Examination of sex across these
subtypes did not yield any significant between-subtype differences
(Discovery: χ2= 1.91; p= 0.38; Replication: χ2= 3.50; p= 0.17),
with a 3:1 to 5:1 sex ratio of males to females. Subtypes did
differ in age at the time of ADI-R interview, with the SC > RRB
group being younger than the other subtypes (Discovery: F
(2,886)= 10.61, p= 2.77e-5; Replication: F(2,887)= 10.80,
p= 2.31e-5). See Table 1 for descriptive statistics.
Contrasting this z-score approach to subtyping with unsuper-
vised clustering methods (Supplementary Fig. 1) that use static
tree cut heights along with internal cluster validation metrics for
choosing the optimal number of clusters, we found that such SC-
RRB balance subtypes are not easily identifiable in a consistent
fashion across Discovery and Replication cohorts with such blind
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methods. However, when using an automated dynamic hybrid
tree-cutting algorithm that adaptively modifies cutting the
dendrogram at different heights25,26, we are able to get relatively
close to finding similar partitions in Discovery (6 subtypes) versus
Replication (7 subtypes) sets (Supplementary Fig. 2).
Replicable subtype-specific functional connectivity differences.
We next evaluated whether such SC-RRB balance subtypes are
differentiated from TD comparison groups in rsfMRI functional
connectivity. Because subtypes are defined based on thresholding
the z-normalized SC-RRB difference score, we identified “con-
sensus edges” as functional connectivity differences between the
autism subtype versus TD that consistently appear across every
z-threshold examined. Figure 3 summarizes the consensus edges
in each subtype for both the LEAP Discovery and Replication
sets. Relative to the TD group, the SC= RRB subtype is char-
acterized by on-average hyperconnectivity between the anterior
salience network (IC07) and a medial motor network (IC13)
(effect sizes at z= 1 threshold: Discovery Cohen’s d= 0.36;
Replication Cohen’s d= 0.51; repBF= 390) as well as hypo-
connectivity between visual association (IC03) and somatomotor
(IC12) networks (effect sizes at z= 1 threshold: Discovery
Cohen’s d=−0.41; Replication Cohen’s d=−0.36; repBF= 16).
The somatomotor network was also hypoconnected in SC > RRB
relative to TD, but with the bilateral perisylvian (IC17) network
(effect sizes at z= 1 threshold: Discovery Cohen’s d=−0.40;
Replication Cohen’s d=−0.41; repBF= 23). In contrast to
comparing autism subtypes to TD, we also directly compared
SC= RRB versus SC > RRB. This analysis did not yield any
significant replicable differences, indicating that while these
subtypes can replicably differ relative to a TD comparison group
in qualitatively unique ways, the difference between each other
may not be replicably large enough to detect at current sample
sizes (effect sizes for z= 1 threshold: IC07-IC13, Discovery
Cohen’s d= 0.10, Replication Cohen’s d= 0.01; IC03-IC12,
Fig. 1 Approach towards testing common pathway versus multiple pathways explanations behind SC-RRB balance in autism. In this figure we depict
two alternatives for how SC-RRB balance subtypes (phenome level; SC= RRB, green; RRB > SC, pink; SC > RRB, blue) could be explained at the level of
macroscale functional connectome phenotypes measured with rsfMRI (connectome level) and autism-associated functional genomic mechanisms (e.g.,
transcriptome and genome levels). Columns in this figure depict the common pathway (middle) and multiple pathways (right) models. The common
pathway model predicts that when each subtype is compared to a typically-developing (TD) comparison group, they converge and share a common
difference from TD in affected macroscale rsfMRI functional connectome phenotype. Underpinning this shared connectome phenotype are a myriad of
differing functional genomic mechanisms. At the level of the transcriptome, we identify genes linked to macroscale functional networks by identifying
genes whose spatial expression pattern across the brain is similar to the spatial topology of the macroscale functional network. This procedure generates a
list of genes relevant for such macroscale networks and these lists are then tested for enrichment in autism-association functional genomic mechanisms.
The gene list at the genome level represents an example of possible autism-associated genes that may (bold) or may not (non-bold) be linked to
macroscale functional networks. In contrast to the common pathway model, the multiple pathways model would highlight that differential connectome
phenotypes when compared to TD are unique to each subtype, and that each of these subtype-specific connectome phenotypes is underpinned by a
differing set of autism-associated functional genomic mechanisms.
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Discovery Cohen’s d=−0.10, Replication Cohen’s d=−0.13;
IC12-IC17, Discovery Cohen’s d= 0.27, Replication Cohen’s
d= 0.11). For the full set of statistical results at z= 1 threshold
across all comparisons see Supplementary Data 2. Thus, the
connectivity results suggest a mixture of some overlap in affected
networks in both subtypes (e.g., IC12), alongside some qualita-
tive specificity of networks affected in only one of the subtypes
(e.g., IC03, IC07, IC13 for SC= RRB; IC17 for SC > RRB).
Importantly, this subtype-distinctiveness is subtle and relative to
TD, but does not heavily differ when subtypes are directly
compared to each other.
Because the subtyping approach uses the difference score
between SC and RRB, this metric does not distinguish individuals
by overall level of severity. For example, an individual with low
SC and RRB severity is treated similarly to an individual with
high SC and RRB severity. This leaves open the possibility that
degree of severity on a continuum from high to low could also
explain variability in functional connectivity. To test this
hypothesis, we constructed a dimensional model to predict
connectivity strength from SC or RRB severity as a continuous
variable. However, there were no instances whereby SC or RRB
severity as a continuous measure could replicably predict
connectivity strength. Similarly, when using the z-normalized
SC-RRB difference score as a continuous variable, we also found
no replicable significant effects on connectivity. For the full set of
statistics see Supplementary Data 2. These results provide a
dimensional model contrast to the categorical subtyping
approach and suggests that modeling continuous SC or RRB
variability may be less sensitive as a predictor of functional
connectivity compared to SC-RRB balance subtypes.
Divergent functional genomic underpinnings of subtype-
specific neural circuitry. In the next analysis, we asked if known
autism-associated genes are enriched amongst genes known to be
highly expressed in these subtype-associated rsfMRI networks. We
first identified lists of genes whose spatial expression topology in
the Allen Institute Human Brain Atlas22 is similar to rsfMRI
Fig. 2 Supervised subtyping of autism by SC-RRB balance. Panel (a) shows the subtypes derived from a z-normalized difference score of SC-RRB, with a
z-score threshold for cutting the subtypes at z= 1. Red shows the RRB > SC subtype, green shows the SC= RRB subtype, and blue shows the SC > RRB
subtype. Panel (b) shows a confusion matrix with actual subtype labels for the NDAR Replication dataset along with the columns and the subtyping
model’s predicted labels (trained on the NDAR Discovery dataset) along the rows. The colors within the cells indicate the percentage of individuals relative
to the actual labels with predicted labels in each cell. Over a range of z-thresholds from 0.5 to 1, the accuracy ranged from 97–99% accuracy. Panel (c)
shows SC-RRB subtypes from the EU-AIMS LEAP datasets derived using norms estimated from NDAR.
Table 1 Participant characteristics from the NDAR datasets.
Discovery Replication
SC > RRB SC= RRB RRB > SC F (p value) SC > RRB SC= RRB RRB > SC F (p value)
N (male) 137 (109) 611 (468) 141 (115) – 124 (97) 629 (482) 137 (115) –
Age in years 7.24 (5.50) 9.03 (5.38) 10.05 (4.02) 10.61 (2.77e-5) 6.92 (5.14) 9.10 (5.54) 9.76 (4.35) 10.80 (2.31e-5)
ADI-R SCb 0.51 (0.13) 0.31 (0.14) 0.21 (0.10) 212.57 (2.2e-16) 191.67 (2.2e-16)
ADI-R RRBb 0.21 (0.10) 0.32 (0.14) 0.49 (0.12) 174.19 (2.2e-16) 184.74 (2.2e-16)
ADOS SA CSSa 7.46 (1.60) 6.92 (2.01) 6.11 (2.49) 2.85 (0.06) 6.96 (1.73) 6.93 (2.04) 6.62 (2.39) 1.83 (0.16)
ADOS RRB CSSa 8.37 (1.31) 7.68 (2.30) 7.37 (2.29) 0.09 (0.91) 7.42 (2.55) 7.40 (2.30) 6.62 (1.06) 0.43 (0.64)
FIQi 106.83 (17.10) 103.89 (18.97) 102.69 (14.59) 0.32 (0.72) 117.27 (13.76) 105.44 (17.96) 106.92 (15.88) 2.38 (0.09)
At a z-threshold of 1, this table shows sample sizes and descriptive statistics (mean and standard deviation) for age and ADOS social affect (SA) and restricted repetitive behaviors (RRB) calibrated
severity scores. The final column on the right shows the F-statistic and p-value from an ANOVA testing for an effect of group. FIQ full-scale IQ, ADI-R autism diagnostic interview revised, ADOS autism
diagnostic observation schedule, SC social-communication, RRB restricted repetitive behaviors, SA social affect, CSS calibrated severity score aSample sizes: ADOS (Discovery, RRB > SC n= 19, SC= RRB
n= 99, SC > RRB n= 35; Replication RRB > SC n= 8, SC= RRB n= 119, SC > RRB n= 26); FIQ (Discovery, RRB > SC n= 39, SC= RRB n= 142, SC > RRB n= 18; Replication RRB > SC n= 40, SC= RRB
n= 135, SC > RRB n= 11). bDSM-5 domain percentage scores used for the SC-RRB difference score computation.
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connectivity networks23 that show replicable subtype differences.
Once a set of genes are predicted to underpin such rsfMRI net-
works, we then asked whether those genes are highly overlapping
with known sets of functional genomic mechanisms linked to
autism (see Fig. 4A for a visual representation of the analysis
approach and Supplementary Data 3 for the full set of gene lists
used in these analyses). Underscoring functional genomic overlap
between the subtypes, all networks except for IC07 were enriched
for a variety of similar autism-associated gene lists—such as, high
penetrance rare de novo protein truncating variants (IC03, IC17),
genes associated with autism from the SFARI Gene database (IC03,
IC12, IC17), genes and co-expression modules that are down-
regulated in expression (IC01, IC03, IC12, IC17), and genes dif-
ferentially expressed in excitatory and inhibitory neurons (IC03,
IC12, IC17) and astrocytes (IC17) (Fig. 4B). Despite this overlap,
our next analysis focused on genes that were specific to networks
affecting only one of the subtypes. To achieve this aim, we
removed genes that showed high levels of expression across mul-
tiple networks. The resulting lists are genes that are expressed
specifically in only one of the networks affecting the SC-RRB
imbalance subtypes. This analysis revealed that genes expressed
SC > RRB-affected networks (i.e., specifically IC17) are enriched
for SFARI ASD genes, autism-downregulated co-expression
modules, and genes differentially expressed in excitatory and
inhibitory neurons and astrocytes. In contrast, genes expressed
within SC= RRB-affected networks (i.e., specifically IC03, IC13,
and IC07) are enriched only for genes downregulated in expression
in autism. Thus, much like the connectivity results, these results
Fig. 3 Replicable subtype differences in functional connectivity. This figure shows chord diagrams of replicable functional connectivity differences
between SC= RRB vs TD (left) or SC > RRB vs TD (right) when subtypes are defined at a z-threshold of 1. However, edges shown in these diagrams are
consensus edges that appear in every analysis of connectivity differences irrespective of the z-threshold used to define the subtypes. Red edges indicate
hyperconnectivity in the autism subtype relative to TD, while blue edges indicate hypoconnectivity in the autism subtype relative to TD. The intensity of
edge color indicates standardized effect size (Cohen’s d) shown on the color bar on the right. The cortical surface renderings of each component are
unthresholded z-stat maps. Areas with higher z-stats (dark red) are of primary importance for the IC map. The top row shows effects in the EU-AIMS LEAP
Discovery set, while the bottom row shows effects in the EU-AIMS LEAP Replication set.
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implicate a mixture of overlap as well as some specificity in the
genomic mechanisms that can affect networks implicated in the
subtypes.
Discussion
In this work, we examined how autism SC-RRB balance subtypes
are atypical at the level of macroscale neural circuitry measured
with rsfMRI. Prior work has theorized that the core dyad of SC
and RRB is fractionable at behavior, neural, and genetic levels4–14.
However, it is unclear whether the road from genome to phe-
nome (e.g., Fig. 1) is one that converges on a common pathway or
is one of multiple pathways15. Here we find evidence consistent
with a mixture of both common and multiple pathways. Con-
sistent with the common pathway hypothesis, we first find no
evidence of strong between-subtype differences in autism when
subtypes are directly compared to each other. Rather, all replic-
able differences in functional connectivity appear when subtypes
are compared to a TD comparison group. Also consistent with
the idea of commonalities between the subtypes is the shared
effect of somatomotor network hypoconnectivity with other
networks. Gene expression decoding analysis of individual net-
works also showed some commonalities in enrichments with
autism-associated gene lists.
Fig. 4 Overlap between genes expressed in functional connectivity networks and genes linked to autism. In panel (a) we depict the analysis approach of
identifying genes that are highly expressed in similar spatial patterns to the rsfMRI spatial IC maps (i.e., gene expression decoding). Once IC gene lists have
been identified, we test these lists for enrichment with known lists of autism-associated functional genomic mechanisms (top left). In panel (b) we show
enrichment odds ratios (numbers in each cell) along with the −log10 p value (coloring of the cells) for enrichment tests of specific networks (columns)
against known lists of autism-associated genomic mechanisms (rows). Cells outlined with thick black rectangles survive FDR q < 0.05. The column labeled SC
> RRB shows the enrichment results when the gene list under consideration comprises genes unique to IC17, but not any of the other ICs. The column labeled
SC= RRB shows the enrichment results when the gene list under consideration consists of genes unique to IC03, IC07, and IC13, but not IC12 or IC17. ASD
dnPTV, Autism de novo protein-truncating variants; ASD SFARI, SFARI Gene autism-associated genes; ASD DE Downreg, autism differentially expressed
downregulated genes; ASD DE Upreg, autism differentially expressed upregulated genes; ASD CTX Downreg CoExpMods, autism downregulated cortical
co-expression modules; ASD CTX Upreg CoExpMods, autism upregulated cortical co-expression modules; ASD Excitatory, autism differentially expressed
genes in excitatory neurons; ASD Inhibitory, autism differentially expressed genes in inhibitory neurons; ASD Microglia, autism differentially expressed genes
in microglia; ASD Oligodendrocyte, autism differentially expressed genes in oligodendrocytes; ASD Astrocyte, autism differentially expressed genes in
astrocytes; ASD Endothelial, autism differentially expressed genes in endothelial cells; SCZ DE, schizophrenia differentially expressed genes; BD DE, bipolar
disorder differentially expressed genes.
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02015-2
6 COMMUNICATIONS BIOLOGY |           (2021) 4:574 | https://doi.org/10.1038/s42003-021-02015-2 | www.nature.com/commsbio
Despite these commonalities, there was also evidence for subtle
distinctions between the subtypes. First, the edges identified as
replicably different between the subtypes relative to TD were
never the same for SC= RRB and SC > RRB subtypes. This effect
indicates that relative to the TD norm, subtle but replicable on-
average differences in network connectivity exist. This highlights
how even though functional neural circuitry organization appears
to be mostly shared between the subtypes, each subtype diverges
slightly but also uniquely from typical development in their
functional organization. It is possible that these on-average sub-
type differences relative to TD are driven by a smaller subset of
individuals within the subtypes with the most dramatic differ-
ences from TD. However, it is also possible that phenotypic
variability within our subtypes might result not simply from
distinct neurocircuitry abnormalities but from more complex and
subtle combinations of shared and divergent neurocircuits
affecting the balance between symptom domains. Second, upon
isolating the genes expressed specifically within subtype-specific
networks, we find a different pattern of autism-associated gene
enrichment. Thus, rather than implicating a commonality in the
genomic mechanisms that underpin different subtypes, this effect
is consistent with the idea that some of the subtype-relevant
genomic mechanisms differentially affect specific neural circuits
such as perisylvian, visual association, or medial motor networks.
Regarding the importance of specific networks identified in our
analyses, the somatomotor network (IC12) has been implicated in
past work on autism. Somatosensory areas have been shown to be
some of the most informative regions in prior case-control classifier
studies using rsfMRI data27. In addition, prior case-control analyses
of the EU-AIMS LEAP dataset find that somatomotor areas show
reduced degree centrality and autism-related hyperconnectivity with
cerebellar networks21,28. However, the lack of somatomotor hypo-
connectivity with visual association or perisylvian networks in prior
case-control studies highlights the potential importance and added
value of subtyping for revealing more subtle effects that can be
masked with case-control contrasts. The perisylvian network that is
hypoconnected with somatomotor circuitry in SC > RRB overlaps
with a variety of areas implicated in the early development of
autism, particularly for auditory processing and language29–33.
Integration of information processing between this network and
others that play a role in embodied somatosensory and social
cognitive processing34,35, such as the somatomotor network (IC12),
could be important for explaining the more pronounced difficulties
these individuals have within SC compared to RRB. Somatomotor
hypoconnectivity with perisylvian auditory and visual association
circuitry could also be important for pointing towards atypical
multisensory integration that has been documented in autism36,37,
particularly with regards to auditory-somatosensory38 and visual-
somatomotor integration39–43.
In addition to somatomotor hypoconnectivity, we also
observed a medial motor network that was hyperconnected to the
anterior salience network in the SC= RRB subtype. The addi-
tional implication of another motor-relevant network in this
subtype underscores the importance of motor circuitry44–46 and
visual-motor integration atypicalities in autism39–43. The anterior
salience network has also been identified in prior case-control
studies. In younger cohorts, anterior salience areas are
hyperconnected47,48, while in older cohorts, hypoconnectivity is
observed49. While the age could be a factor in explaining the
discrepant findings from prior work, it likely cannot explain
the SC= RRB hyperconnectivity finding. Here we age-matched
the groups and additionally included age as a covariate in the
statistical model. EU-AIMS LEAP also samples from a wide
age range from 6 to 30 years of age, enabling the sample to
include younger and older ages covered by prior work. Thus,
age may not be the only explanation for salience network
hyperconnectivity. Rather, this work suggests that SC-RRB het-
erogeneity and the presence of this balanced subtype could also
drive such effects in case-control comparisons, particularly if the
sample is enriched with this particular subtype.
We also identified autism-relevant genomic underpinnings
behind these subtype-specific rsfMRI networks. Genes specific to
SC > RRB networks are enriched for a number of genomic
mechanisms linked to autism such as genes differentially
expressed in excitatory and inhibitory neurons and astrocytes,
downregulated co-expression modules, and high-risk genetic
mutations associated with autism. These genomic underpinnings
suggest that specific neuronal cell types involved in cortical
excitation-inhibition balance50,51 may be especially important for
the SC > RRB subtype. This effect also partially corroborates
evidence suggesting that excitatory neurons are affected in spe-
cific types of autistic individuals that differ in patterns of clinical
severity52. In contrast, SC= RRB networks lacked similar kinds
of enrichments, suggesting that different functional genomic
mechanisms may be linked to this subtype.
Another important finding from the current work is the
absence of replicable connectivity effects in simplistic models that
treat SC and RRB separately as continuous predictors. These
findings suggest that continuous variation (i.e., severity) within
each domain separately may not have a large impact on
explaining variation in functional connectivity. Rather, the SC-
RRB balance subtyping approach of jointly considering the
unique mixture of both SC and RRB within an individual as a
means to then categorically split the autism population into
subtypes could be a more fruitful first pass approach for
explaining connectivity differences. For example, other work also
suggests that categorical factors may be mixed within participants
in a mosaic fashion, whereby different individuals will have dif-
ferent mixtures of continuous differences along the factors53. This
idea of a blend between both categorical and dimensional
explanations for connectivity can be seen in work showing that
etiologically distinct mechanisms known to cause autism result in
continuous differentiation along a manifold landscape of func-
tional connectivity54. Thus, further work might expand on cate-
gorical distinctions put forth by SC-RRB balance models to
explain continuous variability within such subtypes.
There are certain limitations and caveats that need to be dis-
cussed. First, the threshold for the z-score cutoff to define sub-
types could be viewed as arbitrary. However, to guard against this
issue, we re-ran the analysis across a range of thresholds from
z= 0.5 to z= 1 and showed effects that are robust to the
threshold used to label the subtypes. Accuracy for out-of-sample
predictions is also high regardless of the threshold. This effect
occurs largely because the data distributions and statistics used
for the z-normalization are highly similar across large NDAR
Discovery and Replication sets. In a situation where the data
distributions were not similar, this high out-of-sample prediction
accuracy would not have been obtained or may have fluctuated
more substantially at different thresholds. Thus, while the choice
of a threshold may not be well defined, any choice within the
range we have analyzed of z= 0.5 to z= 1, will yield highly
consistent results that are not biased by the choice of a threshold.
The fact that the data distributions and sample statistics used for
the z-normalization were so similar across well-matched NDAR
Discovery and Replication sets allows for high confidence that the
large NDAR dataset is likely very close in accurately estimating
the true population parameters, and this allows for the high
degree of replicability and robustness of the subtyping approach.
Second, the distinctions between these subtypes are not demar-
cated by large categorical separations. As such, when we applied
other canonical unsupervised clustering methods to the data, such
methods were not able to consistently identify the same subtypes
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in independent datasets (Supplementary Fig. 1). An automated
dynamic hybrid tree-cutting method to apply to hierarchical
clustering25,26 was, however, close to deriving relatively similar
subtypes across Discovery and Replication sets (Supplementary
Fig. 2). Future work could explore the utility of this approach and
the consensus subtypes derived from independent datasets with
this methodology. However, the lack of very large separations
between the boundaries for different subtypes of autistic indivi-
duals likely means that a more nuanced and theory-driven
approach may be more fruitful than blind unsupervised approa-
ches. Third, the RRB > SC group was not highly prominent in the
EU-AIMS LEAP cohort. This observation is likely due to the fact
that NDAR includes studies that more heavily sample individuals
from the population with higher RRB severity relative to EU-
AIMS LEAP. For example, ADOS CSS scores for RRB are higher
in NDAR than in LEAP (see Tables 1–2). Because NDAR pools
from a much wider range of studies in different contexts com-
pared to EU-AIMS LEAP, this could be an explanation for this
difference. Fourth, direct comparisons of functional connectivity
between SC= RRB and SC > RRB subtypes did not yield as large
or replicable differences as to when the subtypes are compared to
TD. Thus, while there are unique consensus edges that appear
when the autism subtypes are compared to TD, this result should
not be taken to imply that the subtypes themselves are also highly
different from each other. A likely reason for why these differ-
ences manifest when compared to TD but not when subtypes are
compared directly may be due to effects driven by further subsets
of individuals nested within the larger SC= RRB and SC > RRB
subtypes. Alternatively, it could be that the SC-RRB subtyping
approach does not allow for parsing apart the mechanisms that
clearly distinguish different autistic individuals from each other.
If autistic individuals are mosaics of many complex etiological
mechanisms and those mechanisms have different effects on
functional connectivity, then it may be that models quantifying
such etiological mixtures may be better models of functional
connectivity variation53,54. These individuals at the extremes of
the functional connectivity distributions likely drive the on-
average differences from TD. Future work that digs further into
more granular divisions of the population may likely identify
much larger differences when autism subtypes are compared
directly. Fifth, we also discovered that dimensional models using
continuous SC and RRB severity did not uncover any replicable
associations with functional connectivity strength. This result
could suggest that dimensional model that use continuous
severity from the ADI-R are less effective than the subtyping
approach. However, it could also be that dimensional models
might be more sensitive with other measures of symptomatology
(e.g., ADOS, SRS). Sixth, the subtyping here is based on the ADI-
R. ADI-R is a commonly used “gold standard” diagnostic
instrument to aid clinical judgment regarding an autism diag-
nosis. However, other measures such as the ADOS could also
have been used. For our purposes in this study, we chose to utilize
the ADI-R over the ADOS due to the fact that participants come
from a wide age range, and the ADOS would assess the current
symptomatology of the individual. If age has an effect on
symptomatology55–57, then this could potentially bias the sub-
typing approach depending on the composition of the sample. On
the other hand, because the ADI-R “diagnostic algorithm” utilizes
items that focus on early developmental and “most severe in
lifetime” symptomatology, we do not know how the individual
might have changed across the lifespan of development. In
addition, it may be that measures of current symptomatology
have a stronger association with measures of current functional
connectivity than early childhood and lifetime snapshots of
severity provided by the ADI-R. Future work that looks at how
these ADI-R-derived SC-RRB balance subtypes might change
over time would be informative from a developmental angle. It
would also be important to investigate how observational mea-
sures such as the ADOS might perform as measures of sympto-
matology, especially if conducted within a restricted age range.
Future work might also expand beyond cardinal diagnostic fea-
tures and look into SC and RRB measured as quantitative autistic
traits that expand beyond diagnostic features.
In conclusion, we have shown that SC-RRB balance can point
to different macroscale functional connectivity phenotypes and
potentially different genomic mechanisms that may underpin
such phenotypes. While the divisions between these subtypes at
the phenotypic level are not dramatically evident as categorical
differences, at the level of macroscale neural circuitry, there is
evidence to suggest that these SC-RRB subtypes are different
when compared to the TD population. Future work to study these
fractionable subtypes in an a-priori fashion will benefit from the
use of our simple and supervised subtyping model and will fur-
ther facilitate our understanding of how heterogeneity in autism
manifests in a multi-scale fashion from genome to phenome.
Methods
NDAR Datasets. For the initial set of analyses to derive the approach to char-
acterizing SC and RRB symptom domains, we utilized ADI-R from the National
Database for Autism Research (NDAR). Because individuals can differ over the
lifespan with regard to current symptom presentation, we opted for using the ADI-
R (“diagnostic algorithm” scores) as the measure of symptomatology because it
allows for assessment of symptoms at similar ages regardless of the age of the
participant at the time of testing. This is an important point within the context of
the current study, whereby the age range of the follow-up sample (i.e., EU-AIMS
LEAP) is notably wide (i.e., 6–30 years). Within the SC domain, many items are
rated based on a presentation around 4–5 years of age. This is required because
such items probe behaviors that are developmentally most appropriate in typical
development around this point in the lifespan and the absence of such behaviors in
autistic individuals is of diagnostic importance. In contrast, for many types of RRB
domain items, the presence rather than the absence of such behaviors is of diag-
nostic importance for autism. For these items, the behaviors could occur at any
point during the lifespan and are not developmentally restricted to a specific
age range.
On December 13, 2019, we conducted a search of NDAR to extract all datasets
utilizing the ADI-R58. This resulted in 60 independent datasets totaling 2628
unique individuals. From here, we filtered for all individuals who had data for the
verbal communication items (e.g., acquisition of words, phrases, social
verbalization, chit-chat, reciprocal conversation), leaving a total of 1781 individuals
across 57 independent datasets. Within each of these 57 datasets, we randomly split
the dataset in half to achieve independent Discovery and Replication sets that are
balanced across the 57 datasets and by sex (Discovery n= 889, mean age= 8.91
years, SD age= 5.26 years, 77% male; Replication n= 890, mean age= 8.89 years,
SD age= 5.37 years, 77% male). See Table 1 for characteristics of the NDAR
Discovery and Replication sets. ADI-R item-level data was used to rescore
algorithm totals according to the DSM-559 symptom dyad of social-
communication (SC) and restricted repetitive behavior (RRB) domains. SC is
comprised of three subscales (A1, A2, A3), while RRB is comprised of four
subscales (B1, B2, B3, B4). See Supplementary Table 1 for how items break down
into each domain and subscale within a domain. Only item scores of 0–3
(indicating increasing SC or RRB symptom severity) were utilized, while scores of
6–9 (dummy scores, not indicating symptom severity) were not used. Scores of 3
were kept as is (i.e., not converted to 2 as would typically occur when scoring the
ADI-R algorithm) in order to retain information about severity conveyed by the
difference between a score of 2 versus 3. Because the number of items in each
subscale can vary depending on a person’s age (see Supplementary Table 1) and by
the number of items with possible scores of 0–3, we used percentage scores in order
to ensure that the estimates of severity on each subscale are on a comparable scale
across individuals. These percentage scores for each domain subscale were then
summed and scaled by number of subscales to achieve the final domain total
percentage severity.
Subtyping analyses. To label subtypes by SC-RRB balance, we first computed dif-
ference scores between SC and RRB to estimate the level of SC-RRB balance, whereby
values above 0 indicate an individual with higher SC versus RRB (SC > RRB), whereas
values below 0 indicate the reverse (RRB > SC). These SC-RRB difference scores were
then z-normalized using the mean and standard deviation estimated separately for
Discovery and Replication sets. A z-score cutoff was used to derive subtype labels.
Individuals falling above the z-cutoff (e.g., z > 1) were labeled as SC > RRB, while
individuals falling below the negative value of the z-cutoff (e.g., z <−1) were labeled as
RRB > SC. All individuals between the z-cutoffs were considered SC= RRB. Because
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02015-2
8 COMMUNICATIONS BIOLOGY |           (2021) 4:574 | https://doi.org/10.1038/s42003-021-02015-2 | www.nature.com/commsbio
the choice of a z-cutoff is arbitrary, we ran all analyses across a range of z-thresholds
from z= 0.5 to z= 1, in steps of 0.1. This approach allows us to report results across
thresholds rather than using only one arbitrarily defined threshold. For the later
functional connectivity analyses, this approach also allowed us to identify a consensus
result that is consistent irrespective of the z-threshold used to label subtypes. To make
out-of-sample predictions, we used the mean and SD norms estimated from the
NDAR Discovery set to z-score and label individuals in the NDAR Replication set.
These predicted labels on the Replication set were then compared to the actual subtype
labels computed using the mean and SD norms derived from the Replication set itself.
To make subtype predictions in the EU-AIMS LEAP dataset, we combined both
NDAR Discovery and Replication datasets into one large dataset. From this dataset,
norms for the mean and standard deviation were computed (mean= 0.01045243,
SD= 0.19482749) and used for the z-scoring procedure. SC-RRB difference z-scores
were then computed and a z-threshold was applied to the EU-AIMS LEAP dataset to
generate subtype labels.
In addition to this SC-RRB difference z-score subtyping approach, we also used
other unsupervised clustering methods for identifying subtypes. These methods
utilize agglomerative hierarchical clustering with Euclidean distance and the ward.
D2 method. The optimal number of clusters was determined by a majority vote of
23 different metrics for determining the optimal number of clusters (e.g., using the
NbClust library in R)60. With another approach, we ran the same hierarchical
clustering analyses, but cut dendrograms to define subtypes using a dynamic hybrid
tree cut algorithm, as utilized in past work25,26.
EU-AIMS LEAP dataset. The EU-AIMS LEAP data comes from a large multisite
European initiative with the aim of identifying biomarkers for ASD19. In this study,
EU-AIMS LEAP data is utilized to examine how SC-RRB balance subtypes may
differ in intrinsic functional connectomic organization using rsfMRI data. rsfMRI
data from EU-AIMS LEAP has been analyzed for case-control differences in prior
work21,28. EU-AIMS LEAP recruited 437 individuals with ASD and 300 TD
individuals, both male and female, aged between 6 and 30 years. Participants
underwent comprehensive clinical, cognitive, and MRI assessment at one of the
following five centers: Institute of Psychiatry, Psychology, and Neuroscience, King’s
College London, United Kingdom; Autism Research Centre, University of Cam-
bridge, United Kingdom; Radboud University Nijmegen Medical Centre, the
Netherlands; University Medical Centre Utrecht, the Netherlands; and Central
Institute of Mental Health, Mannheim, Germany. The study was approved by the
local ethical committees of participating centers (see Supplementary Table 2), and
written informed consent was obtained from all participants or their legal guar-
dians (for participants <18 years). For further details about the study design, we
refer to Loth et al.20, and for a comprehensive clinical characterization of the LEAP
cohort, we refer to Charman et al.19. In the present study, we selected all partici-
pants for whom structural and rsfMRI data were available. However, n= 120
participants had to be excluded from the analysis because of missing ADI-R item-
level data (n= 64), missing IQ data (n= 3), or because preprocessing could not be
completed for a variety of reasons (e.g., registration/normalization errors because
of poor quality MPRAGE data, poor anatomical coverage, or large anatomical
deviance such as large ventricles (n= 39), incomplete rsfMRI data (n= 3), errors
in convergence of the ME-ICA algorithm (n= 11)). The final sample size was
n= 266 autistic and n= 243 TD participants. This final sample was split into
independent Discovery and Replication sets (balanced for sex and age) for the
purpose of identifying functional connectivity differences that are replicable. As an
example of sample sizes once split into autism subtypes at a z-threshold of 1, within
the Discovery set there were n= 77 SC= RRB, n= 50 SC > RRB, and n= 121 TD
individuals. Within the Replication set, there were n= 83 SC= RRB, n= 49 SC >
RRB, and n= 122 TD individuals. N= 7 (n= 6 Discovery, n= 1 Replication) were
classified as RRB > SC and because the sample sizes were too small, we did not
analyze this subtype further for functional connectivity differences. We tested
subtypes on a variety of different phenotypic measures including the ADOS-2,
Social Responsiveness Scale (SRS-2), Repetitive Behavior Scale (RBS-R), Short
Sensory Profile (SSP), and the Vineland Adaptive Behavior Scales (VABS). See
Table 2 for participant characteristics.
EU-AIMS LEAP fMRI data acquisition. MRI data were acquired on 3 T scanners:
General Electric MR750 (GE Medical Systems, Milwaukee, WI, USA) at Institute of
Psychiatry, Psychology, and Neuroscience, King’s College London, United King-
dom (KCL); Siemens Magnetom Skyra (Siemens, Erlangen, Germany) at Radboud
University Nijmegen Medical Centre, the Netherlands (RUMC); Siemens Magne-
tom Verio (Siemens, Erlangen, Germany) at the University of Cambridge, United
Kingdom (UCAM); Philips 3 T Achieva (PhilipsHealthcare Systems, Best, The
Netherlands) at University Medical Centre Utrecht, the Netherlands (UMCU); and
Siemens Magnetom Trio (Siemens, Erlangen, Germany) at Central Institute of
Mental Health, Mannheim, Germany (CIMH). Procedures were undertaken to
optimize the MRI sequences for the best scanner-specific options, and phantoms
and travelling heads were employed to assure standardization and quality assur-
ance of the multi-site image-acquisition19. Structural images were obtained using a
5.5 min MPRAGE sequence (TR= 2300 ms, TE= 2.93 ms, T1= 900 ms, voxels
size= 1.1 × 1.1 × 1.2 mm, flip angle= 9°, matrix size= 256 × 256, FOV= 270 mm,
176 slices). An eight-to-ten minute resting-state fMRI (rsfMRI) scan was acquired
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TE~12 ms, 31 ms, and 48 ms (slight variations are present across centers), flip
angle= 80°, matrix size= 64 × 64, in-plane resolution= 3.8 mm, FOV= 240 mm,
33 axial slices, slice thickness/gap= 3.8 mm/0.4 mm, volumes= 200 (UMCU), 215
(KCL, CIMH), or 265 (RUMC, UCAM). Participants were instructed to relax, with
eyes open and fixate on a cross presented on the screen for the duration of the
rsfMRI scan.
EU-AIMS LEAP fMRI preprocessing. Multi-echo rsfMRI data were preprocessed
with the multi-echo independent components analysis (ME-ICA) pipeline,
implemented with the meica python library (v3.2) (https://github.com/ME-ICA/
me-ica). ME-ICA implements both basic fMRI image preprocessing and
decomposition-based denoising that is specifically tailored for multi-echo EPI data.
For the processing of each subject, first, the anatomical image was skull-stripped
and then warped nonlinearly to the MNI anatomical template using AFNI
3dQWarp. The warp field was saved for later application to functional data. For
each functional dataset, the first TE dataset was used to compute parameters of
motion correction and anatomical-functional coregistration, and the first volume
after equilibration was used as the base EPI image. Matrices for de-obliquing and
six-parameter rigid body motion correction were computed. Then, 12-parameter
affine anatomical-functional coregistration was computed using the local Pearson
correlation (LPC) cost functional, using the gray matter segment of the EPI base
image computed with AFNI 3dSeg as the LPC weight mask. Matrices for de-
obliquing, motion correction, and anatomical-functional coregistration were
combined with the standard space nonlinear warp field to create a single warp for
functional data. The dataset of each TE was then slice-time corrected and spatially
aligned through the application of the alignment matrix, and the total nonlinear
warp was applied to the dataset of each TE. No time-series filtering was applied in
the preprocessing phase. No spatial smoothing was applied during preprocessing.
The preprocessed multi-echo time-series datasets were then used by the ME-
ICA pipeline to leverage information in the multiple echoes to compute an optimal
weighting of TE at each voxel63, producing an “optimally combined” time-series
dataset. This optimal combination procedure has been shown to double temporal
signal-to-noise ratio (tSNR) over traditional single echo EPI data64. This
preprocessed optimally combined time-series dataset was then fed into a denoising
procedure based on independent components analysis (ICA) and scoring
components by ρ and κ pseudo-F statistics that indicate degree of TE-
independence or TE-dependence. Components with high ρ and low κ are
components high in non-BOLD related contrast (i.e. non-BOLD artefact signal),
while components with high κ and low ρ indicate components high in BOLD-
related contrast. ME-ICA identifies in an automated fashion high ρ and low κ non-
BOLD components and removes them from the optimally combined time-series
dataset to produce the final multi-echo denoised dataset. This procedure has been
shown to be very effective in removing various types of non-BOLD artefact from
rsfMRI data, including head motion artefact, flattens DVARS traces induced by
head motion, and increases tSNR by a factor of 4 over and above traditional single
echo EPI data61,62,64,65. The final multi-echo denoised datasets were used in further
connectivity analyses. Head motion estimates and DVARS were estimated in order
to show the impact of denoising on reducing non-BOLD artefact due to head
motion (see Supplementary Fig. 3 for examples). In the EU-AIMS LEAP data,
groups did not differ in mean FD (see Table 2).
EU-AIMS LEAP functional connectivity analyses. To assess the large-scale
intrinsic functional organization of the brain we input the multi-echo denoised
data into a group-ICA analysis. Dual regression was then utilized to back-project
spatial maps and individual time-series for each component and subject. Both
group-ICA and dual regression were implemented with FSL’s MELODIC and Dual
Regression tools (www.fmrib.ox.ac.uk/fsl). For group-ICA, we constrained the
dimensionality estimate to 30. Of the 30 final components, 11 were discarded after
visual examination of spatial maps which indicated that they did not correspond to
well-known rsfMRI networks and instead resembled white matter or other
artefacts66. See Supplementary Fig. 4 for a visual depiction of the 19 ICs used in
further analysis.
Time courses for each subject and each independent component (IC) were used
to model between-component connectivity. This was achieved by constructing a
partial correlation matrix amongst all 19 components using Tikhonov-
regularization (i.e., ridge regression, rho= 1) as implemented within the
nets_netmats.m function in the FSLNets MATLAB toolbox (https://fsl.fmrib.ox.ac.
uk/fsl/fslwiki/FSLNets). The aim of utilizing partial correlations was to estimate
direct connection strengths in a more accurate manner than can be achieved with
full correlations, which allow more for indirect connections to influence
connectivity strength67–69. Partial correlations were then converted into Z-statistics
using Fisher’s transformation for further statistical analyses. The lower diagonal of
each subject’s partial correlation matrix was extracted for a total of 171 separate
component-pair comparisons.
To identify replicable subtype effects on functional connectivity, we partitioned
the EU-AIMS LEAP dataset into Discovery and Replication sets. This was achieved
via a random half split of the subtypes within each scanning site and balancing for
sex. TD comparison groups for Discovery and Replication sets were also selected
via a random split balancing sex and achieving an age-match (achieved using the
MatchIt library in R with the default method of nearest neighbor matching).
Models implementing the main hypothesis tests of subtype differences were
computed as linear mixed effect models (lme function from the nlme library in R),
whereby connectivity was the dependent variable, and subtype, sex, and age were
used as fixed effect independent variables and site was modeled with random
intercepts as a random effect. These models were computed separately for the
Discovery and Replication set. Connectivity pairs were deemed as showing
replicable subtype differences if the Discovery set showed an effect at p < 0.05 and
the replication Bayes Factor statistic70 computed on t-statistics from Discovery and
Replication sets were greater than 10 (repBF > 10), indicating strong evidence in
favor of replication.
Because subtyping depends on the choice of a z-threshold, we ran the
connectivity analyses across a range of z-thresholds from z= 0.5 to z= 1, moving
up in steps of 0.1. Across all these z-thresholds, we identified ‘consensus edges’,
defined as replicable subtype connectivity differences that appear at all z-
thresholds. These edges are focused since they are the robust subtype connectivity
differences that are not dependent on a particular z-threshold for labeling the
subtypes. For each threshold, we also counted up the number of edges that are
common across subtypes and with similar directionality in order to estimate how
often subtypes show similar functional connectivity differences.
To contrast the subtyping approach to a more dimensional approach where
z-normalized SC-RRB differences scores are left continuous, we also ran similar
mixed effect models where these continuous scores are the primary independent
variable of interest rather than the subtype variable. Because the z-normalized
difference score does not capture the overall severity level well (e.g., an individual
with low SC and RBB has a difference near 0 just like an individual with high SC
and RRB), we also ran models whereby continuous SC or RRB scores were used as
independent variables rather than the z-normalized difference score. This
allowed for another contrast to test if the overall level of severity within each
domain could explain connectivity strength. In each of these dimensional models,
the same criteria for identifying replicable effects in the subtype models was used
(e.g., p < 0.05 in the Discovery set and a repBF > 10).
Gene expression decoding analyses. To identify genes whose spatial expression
pattern is similar to subtype-specific ICs, we used the Gene Expression Decoding
feature embedded within Neurosynth23 to identify genes that are statistically
similar in their expression profile in a consistent manner across all six donor brains
within the Allen Institute Human Brain Atlas22. The analysis first utilizes a linear
model to compute the similarity between the observed rsfMRI IC map and spatial
patterns of gene expression for each of the six brains in the Allen Institute dataset.
The slopes of these subject-specific linear models encode how similar each gene’s
spatial expression pattern is with our rsfMRI IC maps. These slopes were then
subjected to a one-sample t test to identify genes whose spatial expression patterns
are consistently of high similarity across the donor brains to the rsfMRI IC maps
we input. This analysis was restricted to cortical tissue since all of the networks
being analyzed are primarily cortical. The resulting list of genes was then thre-
sholded for multiple comparisons and only the genes surviving FDR q < 0.05 and
also had a positive t-statistic value were considered.
Enrichment analyses with autism-associated gene lists. To test if network-
associated genes were enriched for different classes of autism-associated genes we
first curated a list of genes known at genetic and transcriptomic levels to be
associated with autism. At the genetic level, we utilized the list of 102 genes
reported by Satterstrom et al.71, which are rare de novo protein-truncating variants
that are associated with a diagnosis of autism (ASD dnPTV). The second list of
autism-associated genes (ASD SFARI) at the genetic level was the list curated by
SFARI Gene (https://gene.sfari.org/). We utilized the entire list of genes in cate-
gories S, 1, 2, and 3 for these analyses (downloaded on July 16, 2020). At the
transcriptomic level, we used several lists. First, we used a list of differentially
expressed genes in autism post-mortem frontal and temporal cortex tissue from
Gandal et al.72, and this list was further split by genes that were downregulated
(ASD DE Downreg) or upregulated (ASD DE Upreg) in autism. To contrast these
enrichments with other psychiatric diagnoses that are genetically correlated with
autism, we also use differentially expressed genes in schizophrenia (SCZ DE) and
bipolar disorder (BD DE), identified from the same Gandal et al., study72. To go
beyond differentially expressed genes in bulk tissue samples, we also examined
autism differentially expressed genes identified in specific cell types—particularly,
excitatory (ASD Excitatory) and inhibitory (ASD Inhibitory) neurons, microglia
(ASD Microglia), astrocytes (ASD Astrocyte), oligodendrocytes (Oligodendrocyte),
and endothelial (ASD Endothelial) cells52. Beyond differentially expressed genes,
we utilized all genes identified in frontal and temporal cortical tissue that were
members of co-expression modules identified to be downregulated (ASD CTX
Downreg CoExpMods) or upregulated (ASD CTX Upreg CoExpMods) in autism73.
All tests of enrichment were conducted with custom code written in R that
computes enrichment odds ratios and p-values based on hypergeometric tests. The
background total for these enrichment tests was set to 20,787, which is the total
number of genes considered by the gene expression decoding analysis in Neuro-
synth. FDR was computed amongst all of the enrichment tests done and only tests
that survived FDR q < 0.05 were interpreted further as statistically significant
enrichments.
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Statistics and reproducibility. The analysis can be reproduced by following the
reproducible analysis documents located in the HTML files in the code directory of
this GitHub repository: https://github.com/IIT-LAND/adir_subtyping.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
NDAR data is available in the National Institute of Mental Health Data Archive (NDA;
https://nda.nih.gov). Tidy data for EU-AIMS is available data directory of this GitHub
repository: https://github.com/IIT-LAND/adir_subtyping.
Code availability
All analysis code for this study is available at https://github.com/IIT-LAND/
adir_subtyping.
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